Fabliha A Chowdhury, Nicole Colussi, Malini Sharma, Katherine C Wood, Julia Z Xu, Bruce A Freeman, Francisco J Schopfer, Adam C Straub
Sickle cell disease (SCD) is a hereditary hematological disease with high morbidity and mortality rates worldwide. Despite being monogenic, SCD patients display a plethora of disease-associated complications including anemia, oxidative stress, sterile inflammation, vaso-occlusive crisis-related pain, and vasculopathy, all of which contribute to multiorgan dysfunction and failure. Over the past decade, numerous small molecule drugs, biologics, and gene-based interventions have been evaluated; however, only four disease-modifying drug therapies are presently FDA approved...
October 24, 2023: Redox Biology